| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GPI anchor binding | 1.11e-05 | 23 | 123 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 2.89e-05 | 29 | 123 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 5.41e-05 | 66 | 123 | 5 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 5.41e-05 | 66 | 123 | 5 | GO:0001098 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 5.51e-05 | 34 | 123 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 7.90e-05 | 14 | 123 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | calmodulin binding | 9.07e-05 | 230 | 123 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.74e-04 | 18 | 123 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.24e-04 | 4 | 123 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | glycolipid binding | 2.34e-04 | 49 | 123 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 5.55e-04 | 6 | 123 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 5.99e-04 | 27 | 123 | 3 | GO:0001091 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 7.41e-04 | 29 | 123 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 7.68e-04 | 316 | 123 | 8 | GO:0035091 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 9.04e-04 | 31 | 123 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 9.18e-04 | 70 | 123 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase inhibitor activity | 1.03e-03 | 8 | 123 | 2 | GO:0141039 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.07e-03 | 73 | 123 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.09e-03 | 33 | 123 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | phosphatase binding | 1.26e-03 | 264 | 123 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | TFIID-class transcription factor complex binding | 1.64e-03 | 10 | 123 | 2 | GO:0001094 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 2.33e-03 | 90 | 123 | 4 | GO:0008028 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.23e-06 | 14 | 125 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.67e-06 | 15 | 125 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.67e-06 | 15 | 125 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.12e-06 | 35 | 125 | 5 | GO:1901142 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 2.21e-06 | 16 | 125 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 2.88e-06 | 17 | 125 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 2.88e-06 | 17 | 125 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | magnesium ion homeostasis | 2.88e-06 | 17 | 125 | 4 | GO:0010960 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 3.68e-06 | 18 | 125 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 5.78e-06 | 20 | 125 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 7.10e-06 | 21 | 125 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.16e-05 | 49 | 125 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 2.02e-05 | 27 | 125 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 2.25e-05 | 56 | 125 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule binding | 3.64e-05 | 2 | 125 | 2 | GO:1904527 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 4.05e-05 | 32 | 125 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 4.05e-05 | 32 | 125 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 4.59e-05 | 33 | 125 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 5.18e-05 | 34 | 125 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 7.13e-05 | 71 | 125 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 8.09e-05 | 38 | 125 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 8.97e-05 | 39 | 125 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 9.37e-05 | 15 | 125 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 9.37e-05 | 15 | 125 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.07e-04 | 178 | 125 | 7 | GO:0022612 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.39e-04 | 17 | 125 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.58e-04 | 45 | 125 | 4 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.72e-04 | 46 | 125 | 4 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.72e-04 | 46 | 125 | 4 | GO:0072574 | |
| GeneOntologyBiologicalProcess | response to hormone | CEACAM5 CEACAM8 SREBF2 CEACAM6 NCF2 CPN1 PIAS2 CEACAM1 NCOR2 FAT1 KL LNPEP TMF1 PRKCE PRLR TBX2 SORL1 | 1.85e-04 | 1042 | 125 | 17 | GO:0009725 |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.87e-04 | 47 | 125 | 4 | GO:0015721 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 2.21e-04 | 49 | 125 | 4 | GO:0002837 | |
| GeneOntologyBiologicalProcess | liver development | 2.34e-04 | 202 | 125 | 7 | GO:0001889 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 2.39e-04 | 50 | 125 | 4 | GO:0002834 | |
| GeneOntologyBiologicalProcess | energy homeostasis | 2.47e-04 | 144 | 125 | 6 | GO:0097009 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 2.56e-04 | 205 | 125 | 7 | GO:0061008 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 2.67e-04 | 21 | 125 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 2.67e-04 | 21 | 125 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 3.08e-04 | 22 | 125 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 3.52e-04 | 23 | 125 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.52e-04 | 23 | 125 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | lncRNA transcription | 3.60e-04 | 5 | 125 | 2 | GO:0140742 | |
| GeneOntologyBiologicalProcess | endosome to plasma membrane protein transport | 4.01e-04 | 24 | 125 | 3 | GO:0099638 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 4.01e-04 | 24 | 125 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 4.01e-04 | 24 | 125 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 4.01e-04 | 24 | 125 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 4.53e-04 | 25 | 125 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 4.53e-04 | 25 | 125 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | CEACAM5 CEACAM8 CEACAM6 NCF2 PIAS2 CEACAM1 NCOR2 FAT1 TMF1 PRKCE PRLR TBX2 SORL1 | 4.74e-04 | 727 | 125 | 13 | GO:0032870 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 4.82e-04 | 60 | 125 | 4 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 5.14e-04 | 61 | 125 | 4 | GO:0060259 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol import | 5.38e-04 | 6 | 125 | 2 | GO:1904109 | |
| GeneOntologyBiologicalProcess | gland development | TET2 CEACAM5 CEACAM8 E2F7 ETV4 CEACAM6 CEACAM1 NCOR2 DNAAF1 PRLR TBX2 | 5.92e-04 | 558 | 125 | 11 | GO:0048732 |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 6.37e-04 | 28 | 125 | 3 | GO:0090306 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 6.37e-04 | 28 | 125 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 6.93e-04 | 66 | 125 | 4 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 7.08e-04 | 29 | 125 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | CEACAM5 DOCK8 WASHC1 CEACAM6 CEACAM1 WASH6P NFATC2 TMEM131L PRLR | 7.24e-04 | 398 | 125 | 9 | GO:0046651 |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 8.20e-04 | 69 | 125 | 4 | GO:0030195 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | CEACAM5 DOCK8 WASHC1 CEACAM6 CEACAM1 WASH6P NFATC2 TMEM131L PRLR | 8.33e-04 | 406 | 125 | 9 | GO:0032943 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 8.63e-04 | 31 | 125 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 8.65e-04 | 70 | 125 | 4 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of immune response | CEACAM5 GBP7 WASHC1 CEACAM6 TRAC ECM1 ERBIN CREBBP MAP3K1 CEACAM1 WASH6P PJA2 NFATC2 HPX HRG PRKCE | 8.68e-04 | 1085 | 125 | 16 | GO:0050776 |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 9.13e-04 | 71 | 125 | 4 | GO:0043114 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 9.48e-04 | 32 | 125 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 9.62e-04 | 72 | 125 | 4 | GO:0050819 | |
| GeneOntologyBiologicalProcess | ribosomal small subunit export from nucleus | 9.96e-04 | 8 | 125 | 2 | GO:0000056 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 1.01e-03 | 73 | 125 | 4 | GO:0042304 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.04e-03 | 33 | 125 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | regulation of ketone metabolic process | 1.04e-03 | 189 | 125 | 6 | GO:0010565 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.13e-03 | 34 | 125 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol import | 1.28e-03 | 9 | 125 | 2 | GO:0060620 | |
| GeneOntologyBiologicalProcess | regulation of microtubule binding | 1.28e-03 | 9 | 125 | 2 | GO:1904526 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 2.10e-06 | 16 | 125 | 4 | GO:0070021 | |
| MousePheno | decreased carbon dioxide production | 2.36e-06 | 31 | 99 | 5 | MP:0008964 | |
| MousePheno | insulin resistance | CEACAM5 CEACAM8 CRELD2 CEACAM6 CPE CREBBP CEACAM1 NCOR2 LNPEP | 1.06e-05 | 197 | 99 | 9 | MP:0005331 |
| MousePheno | increased skeletal muscle triglyceride level | 1.29e-05 | 21 | 99 | 4 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 2.26e-05 | 24 | 99 | 4 | MP:0014172 | |
| MousePheno | increased circulating leptin level | 2.91e-05 | 125 | 99 | 7 | MP:0005669 | |
| MousePheno | increased abdominal fat pad weight | 3.67e-05 | 27 | 99 | 4 | MP:0009286 | |
| MousePheno | impaired long-term object recognition memory | 4.25e-05 | 28 | 99 | 4 | MP:0014367 | |
| MousePheno | abnormal circulating leptin level | 4.43e-05 | 236 | 99 | 9 | MP:0005667 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 6.43e-05 | 31 | 99 | 4 | MP:0031413 | |
| MousePheno | abnormal oxygen consumption | 7.19e-05 | 195 | 99 | 8 | MP:0005288 | |
| MousePheno | abnormal energy expenditure | CEACAM5 CEACAM8 CEACAM6 CPE CREBBP CEACAM1 PASK NCOR2 LNPEP AHNAK | 7.34e-05 | 313 | 99 | 10 | MP:0005450 |
| MousePheno | abnormal energy homeostasis | CEACAM5 CEACAM8 CEACAM6 CPE CREBBP CEACAM1 PASK NCOR2 LNPEP AHNAK | 9.29e-05 | 322 | 99 | 10 | MP:0005448 |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.05e-04 | 35 | 99 | 4 | MP:0031618 | |
| MousePheno | abnormal carbon dioxide production | 1.10e-04 | 67 | 99 | 5 | MP:0008962 | |
| MousePheno | abnormal muscle triglyceride level | 1.17e-04 | 36 | 99 | 4 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 1.61e-04 | 39 | 99 | 4 | MP:0030022 | |
| MousePheno | increased hormone level | CEACAM5 CEACAM8 CEACAM6 CPE COG3 PIAS2 CREBBP ALG2 CEACAM1 NCOR2 TMEM174 KL LNPEP PRLR | 1.62e-04 | 641 | 99 | 14 | MP:0014454 |
| MousePheno | abnormal vascular wound healing | 1.65e-04 | 73 | 99 | 5 | MP:0004883 | |
| MousePheno | abnormal adipose tissue amount | CEACAM5 TSPOAP1 CEACAM8 CEACAM6 CPE ZCCHC2 USH1C PIAS2 CREBBP RYR1 CEACAM1 ZNF462 NCOR2 KL PSIP1 LNPEP AHNAK EFR3B PRKCE | 1.72e-04 | 1077 | 99 | 19 | MP:0005452 |
| MousePheno | increased circulating insulin level | 1.77e-04 | 283 | 99 | 9 | MP:0002079 | |
| MousePheno | abnormal insulin secretion | 2.10e-04 | 171 | 99 | 7 | MP:0003564 | |
| MousePheno | increased circulating hormone level | CEACAM5 CEACAM8 CEACAM6 CPE COG3 PIAS2 CREBBP ALG2 CEACAM1 TMEM174 KL LNPEP PRLR | 2.13e-04 | 578 | 99 | 13 | MP:0014456 |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 2.18e-04 | 17 | 99 | 3 | MP:0031047 | |
| MousePheno | abnormal circulating insulin level | CEACAM5 CEACAM8 CEACAM6 CPE COG3 PIAS2 CREBBP ALG2 CEACAM1 PASK NCOR2 KL | 2.30e-04 | 505 | 99 | 12 | MP:0001560 |
| MousePheno | decreased oxygen consumption | 2.40e-04 | 79 | 99 | 5 | MP:0005290 | |
| MousePheno | abnormal endocrine pancreas secretion | 2.50e-04 | 176 | 99 | 7 | MP:0014195 | |
| MousePheno | polyphagia | 2.54e-04 | 80 | 99 | 5 | MP:0001433 | |
| MousePheno | abnormal long-term object recognition memory | 2.59e-04 | 44 | 99 | 4 | MP:0002801 | |
| MousePheno | abnormal respiratory quotient | 2.68e-04 | 178 | 99 | 7 | MP:0004129 | |
| MousePheno | abnormal gas homeostasis | DDAH1 CEACAM5 CEACAM8 CEACAM6 CPE CREBBP RYR1 CEACAM1 PASK NCOR2 LNPEP VCAN PRKCE | 3.06e-04 | 600 | 99 | 13 | MP:0003948 |
| MousePheno | abnormal pancreas secretion | 3.17e-04 | 183 | 99 | 7 | MP:0002694 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 3.34e-04 | 47 | 99 | 4 | MP:0031617 | |
| MousePheno | abnormal glucose tolerance | CEACAM5 CEACAM8 CEACAM6 CPE USH1C CREBBP CEACAM1 ZNF462 PASK KL LNPEP AHNAK SCN3A EFR3B PRLR | 4.07e-04 | 787 | 99 | 15 | MP:0005291 |
| MousePheno | abnormal object recognition memory | 4.39e-04 | 90 | 99 | 5 | MP:0001458 | |
| MousePheno | abnormal pancreatic beta cell physiology | 4.80e-04 | 196 | 99 | 7 | MP:0003562 | |
| MousePheno | decreased cellular glucose uptake | 5.31e-04 | 53 | 99 | 4 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 5.71e-04 | 54 | 99 | 4 | MP:0010953 | |
| MousePheno | abnormal endocrine pancreas physiology | 5.75e-04 | 202 | 99 | 7 | MP:0010147 | |
| MousePheno | broad nasal bone | 7.31e-04 | 6 | 99 | 2 | MP:0004472 | |
| Domain | DUF21 | 1.68e-09 | 4 | 121 | 4 | IPR002550 | |
| Domain | DUF21 | 1.68e-09 | 4 | 121 | 4 | PF01595 | |
| Domain | CBS_dom | 7.49e-06 | 20 | 121 | 4 | IPR000644 | |
| Domain | CBS | 7.49e-06 | 20 | 121 | 4 | PF00571 | |
| Domain | CBS | 7.49e-06 | 20 | 121 | 4 | PS51371 | |
| Domain | Ryanodine_rcpt | 1.24e-04 | 3 | 121 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.24e-04 | 3 | 121 | 2 | IPR009460 | |
| Domain | RyR | 1.24e-04 | 3 | 121 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.24e-04 | 3 | 121 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.24e-04 | 3 | 121 | 2 | IPR013333 | |
| Domain | - | 2.62e-04 | 48 | 121 | 4 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 3.31e-04 | 51 | 121 | 4 | IPR014710 | |
| Domain | RIH_assoc-dom | 6.14e-04 | 6 | 121 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 6.14e-04 | 6 | 121 | 2 | PF08709 | |
| Domain | RIH_assoc | 6.14e-04 | 6 | 121 | 2 | PF08454 | |
| Domain | RIH_dom | 6.14e-04 | 6 | 121 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 6.14e-04 | 6 | 121 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 6.14e-04 | 6 | 121 | 2 | IPR015925 | |
| Domain | - | 6.14e-04 | 6 | 121 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 6.14e-04 | 6 | 121 | 2 | PF01365 | |
| Domain | Ig-like_fold | PAPPA2 CEACAM5 TSPOAP1 TRA CEACAM8 CEACAM6 CEACAM1 NFATC2 VCAN LSAMP FNDC8 PRLR SORL1 | 6.64e-04 | 706 | 121 | 13 | IPR013783 |
| Domain | - | PAPPA2 CEACAM5 TSPOAP1 CEACAM8 CEACAM6 CEACAM1 NFATC2 VCAN LSAMP FNDC8 PRLR SORL1 | 1.25e-03 | 663 | 121 | 12 | 2.60.40.10 |
| Domain | Ig_2 | 1.29e-03 | 73 | 121 | 4 | PF13895 | |
| Domain | MIR | 1.81e-03 | 10 | 121 | 2 | PF02815 | |
| Domain | MIR_motif | 1.81e-03 | 10 | 121 | 2 | IPR016093 | |
| Domain | MIR | 1.81e-03 | 10 | 121 | 2 | PS50919 | |
| Domain | MIR | 1.81e-03 | 10 | 121 | 2 | SM00472 | |
| Domain | PDZ | 2.25e-03 | 141 | 121 | 5 | PF00595 | |
| Domain | PDZ | 2.78e-03 | 148 | 121 | 5 | SM00228 | |
| Domain | - | 2.95e-03 | 150 | 121 | 5 | 2.30.42.10 | |
| Domain | PDZ | 3.03e-03 | 151 | 121 | 5 | PS50106 | |
| Domain | CarboxyPept_regulatory_dom | 3.10e-03 | 13 | 121 | 2 | IPR014766 | |
| Domain | - | 3.10e-03 | 13 | 121 | 2 | 2.60.40.1120 | |
| Domain | PDZ | 3.12e-03 | 152 | 121 | 5 | IPR001478 | |
| Domain | PB1 | 3.60e-03 | 14 | 121 | 2 | SM00666 | |
| Domain | PB1 | 3.60e-03 | 14 | 121 | 2 | PF00564 | |
| Domain | PB1 | 3.60e-03 | 14 | 121 | 2 | PS51745 | |
| Domain | PB1_dom | 3.60e-03 | 14 | 121 | 2 | IPR000270 | |
| Domain | CarboxyPept-like_regulatory | 5.31e-03 | 17 | 121 | 2 | IPR008969 | |
| Domain | Zn_pept | 5.95e-03 | 18 | 121 | 2 | SM00631 | |
| Domain | Ion_trans_dom | 6.47e-03 | 114 | 121 | 4 | IPR005821 | |
| Domain | Ion_trans | 6.47e-03 | 114 | 121 | 4 | PF00520 | |
| Pathway | REACTOME_FIBRONECTIN_MATRIX_FORMATION | 5.13e-06 | 6 | 91 | 3 | M26970 | |
| Pubmed | 1.64e-10 | 4 | 126 | 4 | 26483485 | ||
| Pubmed | 1.64e-10 | 4 | 126 | 4 | 12657465 | ||
| Pubmed | Molecular cloning and characterization of the mouse Acdp gene family. | 1.64e-10 | 4 | 126 | 4 | 14723793 | |
| Pubmed | 1.64e-10 | 4 | 126 | 4 | 21393841 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 25409014 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 17167768 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 31171910 | ||
| Pubmed | 1.60e-07 | 14 | 126 | 4 | 11994468 | ||
| Pubmed | 1.60e-07 | 14 | 126 | 4 | 20381490 | ||
| Pubmed | 1.60e-07 | 14 | 126 | 4 | 23469261 | ||
| Pubmed | 1.60e-07 | 14 | 126 | 4 | 22159884 | ||
| Pubmed | 1.60e-07 | 14 | 126 | 4 | 28567513 | ||
| Pubmed | 1.60e-07 | 14 | 126 | 4 | 8207827 | ||
| Pubmed | CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. | 1.60e-07 | 14 | 126 | 4 | 27161904 | |
| Pubmed | 1.60e-07 | 14 | 126 | 4 | 23070997 | ||
| Pubmed | 1.60e-07 | 14 | 126 | 4 | 10491101 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 10436421 | ||
| Pubmed | Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. | 1.85e-07 | 4 | 126 | 3 | 27748768 | |
| Pubmed | Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA. | 1.85e-07 | 4 | 126 | 3 | 27748756 | |
| Pubmed | Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells. | 1.85e-07 | 4 | 126 | 3 | 19077207 | |
| Pubmed | 2.17e-07 | 15 | 126 | 4 | 24948196 | ||
| Pubmed | 2.17e-07 | 15 | 126 | 4 | 20410265 | ||
| Pubmed | 2.17e-07 | 15 | 126 | 4 | 26586918 | ||
| Pubmed | 2.89e-07 | 16 | 126 | 4 | 23123061 | ||
| Pubmed | 2.89e-07 | 16 | 126 | 4 | 25085348 | ||
| Pubmed | Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. | 2.89e-07 | 16 | 126 | 4 | 11284729 | |
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 4.62e-07 | 5 | 126 | 3 | 19011160 | |
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 4.62e-07 | 5 | 126 | 3 | 11701968 | |
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 9.21e-07 | 6 | 126 | 3 | 18159949 | |
| Pubmed | A secreted protein microarray platform for extracellular protein interaction discovery. | 1.18e-06 | 51 | 126 | 5 | 21982860 | |
| Pubmed | SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. | 1.61e-06 | 7 | 126 | 3 | 23415230 | |
| Pubmed | In vivo validation of late-onset Alzheimer's disease genetic risk factors. | 1.96e-06 | 25 | 126 | 4 | 38687251 | |
| Pubmed | Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region. | 2.57e-06 | 8 | 126 | 3 | 10655549 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ATMIN FRYL CEP192 PIP5K1C DENND1A RYR1 SCAF1 NCOR2 FAT1 SH3TC1 AHNAK ZNF408 ZNF500 PYGB ULK4 AHNAK2 | 2.62e-06 | 1105 | 126 | 16 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 SORBS2 MAP2 KDM5A FRYL CEP192 ERBIN DENND1A PJA2 AHNAK PRKCE BOD1L1 MAP3K2 AHNAK2 | 3.11e-06 | 861 | 126 | 14 | 36931259 |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.29e-05 | 13 | 126 | 3 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.29e-05 | 13 | 126 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.29e-05 | 13 | 126 | 3 | 16638824 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 20044046 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 32150576 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 6265583 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.29e-05 | 13 | 126 | 3 | 12832451 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.29e-05 | 13 | 126 | 3 | 21670291 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 22162753 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 2702644 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 8380065 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 1279194 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 25724769 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.29e-05 | 13 | 126 | 3 | 22092845 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 11801635 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.29e-05 | 13 | 126 | 3 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.29e-05 | 13 | 126 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.29e-05 | 13 | 126 | 3 | 23800882 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 19285068 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 21760897 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.29e-05 | 13 | 126 | 3 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.29e-05 | 13 | 126 | 3 | 39168268 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 8402684 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 16619040 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.29e-05 | 13 | 126 | 3 | 8209741 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.29e-05 | 13 | 126 | 3 | 21949477 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 26219866 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 2133556 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 32521208 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 19406938 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.29e-05 | 13 | 126 | 3 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.29e-05 | 13 | 126 | 3 | 19358828 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 16680193 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.29e-05 | 13 | 126 | 3 | 34058224 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 10964771 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 32169849 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.29e-05 | 13 | 126 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.29e-05 | 13 | 126 | 3 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.29e-05 | 13 | 126 | 3 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.29e-05 | 13 | 126 | 3 | 23935487 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 15331748 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.29e-05 | 13 | 126 | 3 | 22406619 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.29e-05 | 13 | 126 | 3 | 25972571 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 19008452 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.29e-05 | 13 | 126 | 3 | 15220458 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 18843289 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 15207636 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 21081647 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 11133662 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 11483763 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 2164599 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 29396368 | ||
| Interaction | NUP43 interactions | RANBP1 LRP12 CENPC KDM5A NUP88 CCDC168 ZNF462 SCAF1 NCOR2 NOP58 PSIP1 HLTF ACIN1 BOD1L1 DNAH9 AHNAK2 | 1.83e-06 | 625 | 126 | 16 | int:NUP43 |
| Interaction | CEACAM1 interactions | 8.03e-06 | 21 | 126 | 4 | int:CEACAM1 | |
| Cytoband | 10q24.2 | 2.99e-05 | 22 | 126 | 3 | 10q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q24 | 1.83e-04 | 189 | 126 | 5 | chr10q24 | |
| Cytoband | 9p22.3 | 5.71e-04 | 13 | 126 | 2 | 9p22.3 | |
| Cytoband | 9p24.3 | 6.66e-04 | 14 | 126 | 2 | 9p24.3 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 3.71e-06 | 24 | 81 | 4 | 906 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 4.65e-05 | 16 | 81 | 3 | 14 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 5.93e-05 | 3 | 81 | 2 | 287 | |
| GeneFamily | PDZ domain containing | 6.03e-04 | 152 | 81 | 5 | 1220 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 8.26e-04 | 163 | 81 | 5 | 590 | |
| GeneFamily | Carboxypeptidases | 3.94e-03 | 21 | 81 | 2 | 1321 | |
| GeneFamily | PWWP domain containing | 4.32e-03 | 22 | 81 | 2 | 1147 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.00e-07 | 180 | 124 | 9 | M8239 | |
| Coexpression | HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN | 1.33e-05 | 64 | 124 | 5 | M999 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CENPC KDM5A DOCK8 FRYL ERBIN CREBBP PCF11 STYX PSIP1 NFATC2 LNPEP AHNAK TMF1 TMEM131L BOD1L1 ITM2B ARHGEF6 LRRFIP1 MAP3K2 SORL1 | 2.31e-05 | 1492 | 124 | 20 | M40023 |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 2.89e-05 | 75 | 124 | 5 | MM605 | |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 4.09e-05 | 195 | 124 | 7 | M7310 | |
| Coexpression | GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP | 4.80e-05 | 200 | 124 | 7 | M8200 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP | 4.80e-05 | 200 | 124 | 7 | M9895 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | LRP12 THSD7A MAP2 COG3 USP37 PIAS2 PCF11 ZNF462 TTBK2 STYX PSIP1 LNPEP VCAN SCN3A LSAMP WDR44 | 2.41e-05 | 836 | 122 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | SORBS2 THSD7A MAP2 CRELD2 CEP192 ZCCHC2 ZNF462 CNNM3 FAT1 NRXN2 SPON1 TMF1 RPUSD2 ACIN1 MCOLN3 LRRFIP1 WDR44 | 5.42e-05 | 994 | 122 | 17 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | RANBP1 CENPC E2F7 CEP192 USP37 PCF11 PSIP1 NDC80 TMF1 RPUSD2 ACIN1 WDR44 | 5.76e-05 | 532 | 122 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.17e-05 | 176 | 122 | 7 | gudmap_developingKidney_e15.5_S-shaped body_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | RANBP1 SORBS2 MAP2 ZNF462 NCOR2 FAT1 NRXN2 RPUSD2 ACIN1 WDR44 | 9.60e-05 | 395 | 122 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | CEP192 USP37 CREBBP ZNF462 CNNM4 NOP9 TMF1 BOD1L1 PWWP3B FILIP1L TBX2 | 1.28e-04 | 492 | 122 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | SORBS2 THSD7A MAP2 E2F7 PIAS2 FREM1 ZNF462 LNPEP SPON1 VCAN SCN3A HLTF LSAMP SORL1 | 1.36e-04 | 769 | 122 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-08 | 193 | 126 | 8 | 1526f51b589a7dc7a28f35f0e788dc38d338d2bc | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.06e-07 | 200 | 126 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.37e-07 | 177 | 126 | 7 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.89e-07 | 182 | 126 | 7 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 9.56e-07 | 184 | 126 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-06 | 186 | 126 | 7 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 191 | 126 | 7 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.36e-06 | 194 | 126 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-06 | 195 | 126 | 7 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 1.46e-06 | 196 | 126 | 7 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.48e-06 | 144 | 126 | 6 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.51e-06 | 156 | 126 | 6 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 174 | 126 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.03e-05 | 174 | 126 | 6 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 175 | 126 | 6 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.13e-05 | 177 | 126 | 6 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.17e-05 | 178 | 126 | 6 | 0139b42494c1186390b12106dea7957e2b6717c2 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 178 | 126 | 6 | 416f85e51f45ec7949451fd47611a84e33e87245 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 179 | 126 | 6 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 181 | 126 | 6 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.33e-05 | 182 | 126 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-05 | 184 | 126 | 6 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 185 | 126 | 6 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-05 | 187 | 126 | 6 | 1eed2c1a05e80a7c8f639437c117afe0c18dfb0c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 187 | 126 | 6 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.60e-05 | 188 | 126 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.60e-05 | 188 | 126 | 6 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 188 | 126 | 6 | 90188b60ff893754f7938fe8edab79758827168e | |
| ToppCell | Control-Myeloid-Monocytes|Control / group, cell type (main and fine annotations) | 1.65e-05 | 189 | 126 | 6 | 3335d16bd0ffa0c1ddd06d7da645299148130c3f | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.65e-05 | 189 | 126 | 6 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.65e-05 | 189 | 126 | 6 | 55aba1ebc012006a5db3ff9c92589cb3d9f7c68a | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 189 | 126 | 6 | 27e5d706f10a6221f314faf642eede15deab3165 | |
| ToppCell | (5)_Epi_upper|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.80e-05 | 192 | 126 | 6 | 0c8f73cfd24531a040544df39f28626433aaa651 | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_upper|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.80e-05 | 192 | 126 | 6 | 69b6b3ceaad6432c46d1bc2a00b8389069a8876e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-05 | 192 | 126 | 6 | 1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.80e-05 | 192 | 126 | 6 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.83e-05 | 114 | 126 | 5 | 108cc5b04cc7c59310eb55dc2c44ae2b8e0b05e4 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-05 | 193 | 126 | 6 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 193 | 126 | 6 | b9e11cd0896c0868aab7faec4ab7ab4d4e4d1b47 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.85e-05 | 193 | 126 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 193 | 126 | 6 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-05 | 193 | 126 | 6 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | background-Cholangiocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.85e-05 | 193 | 126 | 6 | 9152241073dbe02ac2c11d86bec9b5b529196f6e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 193 | 126 | 6 | f25bdd10ef531b8d8441ea84573078b4b1b0f105 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-05 | 194 | 126 | 6 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.96e-05 | 195 | 126 | 6 | ae98215b7b7f22f1aca690920ce6092dc4a3c7db | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.96e-05 | 195 | 126 | 6 | 6fcab7aa4db958ccad0300adea9aaae52ace5bff | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-05 | 195 | 126 | 6 | b21bf50d689fc3b933182f4bfdde82f375257b72 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.96e-05 | 195 | 126 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius-36|World / Primary Cells by Cluster | 1.96e-05 | 195 | 126 | 6 | bc76a0586cc78f013cb96a2444e63e3c5daa3bc7 | |
| ToppCell | BLOOD--(1)_T_cell-(1)_EM_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.96e-05 | 195 | 126 | 6 | 4b8831ed8fb73579f49604eeda8a3b2344e69f0e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius|World / Primary Cells by Cluster | 1.96e-05 | 195 | 126 | 6 | 424d8e2bc7f7e68f74219de06dbbb671c8b4c24c | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-05 | 195 | 126 | 6 | b5db3c0e3a41f68fca18e0a74e1b7e81df4f94c5 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-05 | 196 | 126 | 6 | 95544097577f20ed7f4144bd940471cde0617554 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.02e-05 | 196 | 126 | 6 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.08e-05 | 197 | 126 | 6 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 2.14e-05 | 198 | 126 | 6 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-05 | 199 | 126 | 6 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 2.20e-05 | 199 | 126 | 6 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 2.20e-05 | 199 | 126 | 6 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-05 | 199 | 126 | 6 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.26e-05 | 200 | 126 | 6 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | 5432bdf495431cd26f6e4cd585100f3652588913 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.26e-05 | 200 | 126 | 6 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.26e-05 | 200 | 126 | 6 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.96e-05 | 126 | 126 | 5 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.98e-05 | 134 | 126 | 5 | 657ad905b40ec3f82acdef824431b8276d291ef7 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.98e-05 | 134 | 126 | 5 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 4.12e-05 | 135 | 126 | 5 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.80e-05 | 150 | 126 | 5 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 7.24e-05 | 152 | 126 | 5 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.94e-05 | 155 | 126 | 5 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | 18-Distal-Epithelial-Basal_cell|Distal / Age, Tissue, Lineage and Cell class | 8.69e-05 | 158 | 126 | 5 | 183f445967e09e871c93d8e94781ed9fec894169 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.96e-05 | 159 | 126 | 5 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 8.96e-05 | 159 | 126 | 5 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.96e-05 | 159 | 126 | 5 | b1d5ebd0c186b6d0279dab20d8f3b4a915acdc1f | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tregs|GI_large-bowel / Manually curated celltypes from each tissue | 9.78e-05 | 162 | 126 | 5 | 9a5e65c45f73a6a685b8362aa2e6aea77181caa3 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 164 | 126 | 5 | b81498c3934e0d52bf0329dc745e02966f9d8613 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 166 | 126 | 5 | d96c562e1483adb4cdd817b68133f03356d7279b | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 168 | 126 | 5 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | facs-Kidney|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 168 | 126 | 5 | d2f17a470e04f8f0edb111894027bcfc6ee1a12f | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.19e-04 | 169 | 126 | 5 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.19e-04 | 169 | 126 | 5 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 169 | 126 | 5 | 813472d429c0b12580b17b440e00a6d8beb7947f | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.23e-04 | 170 | 126 | 5 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-new-cluster|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 170 | 126 | 5 | 4fb4ce46e4fa2418238e264875209d7ebe844d82 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-04 | 170 | 126 | 5 | 51dbfa07daf6f972b566f3f6abe7f46e080ec01c | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 171 | 126 | 5 | c6fc9ef9735dbf5314a4c7dac2b2954b0985ae4d | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 171 | 126 | 5 | 55b194a9bf4d3e4b5d96e0d1298424359c441cbb | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 171 | 126 | 5 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-04 | 171 | 126 | 5 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 171 | 126 | 5 | a31c23406cf6d6a17358a8fb41d392a7fb0306e0 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 171 | 126 | 5 | 43d8fd9b9546e84a652564fe96b514b34b06262b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-04 | 171 | 126 | 5 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-04 | 171 | 126 | 5 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-04 | 171 | 126 | 5 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-04 | 172 | 126 | 5 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-04 | 173 | 126 | 5 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| Computational | Neighborhood of REV3L | 8.08e-05 | 58 | 83 | 5 | MORF_REV3L | |
| Drug | AC1L1IPV | 3.75e-06 | 43 | 125 | 5 | CID000004683 | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 1.25e-05 | 195 | 125 | 8 | 6971_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.35e-05 | 197 | 125 | 8 | 3433_DN | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 1.40e-05 | 198 | 125 | 8 | 7521_DN | |
| Drug | Alfaxalone [23930-19-0]; Up 200; 12uM; HL60; HT_HG-U133A | 1.40e-05 | 198 | 125 | 8 | 3135_UP | |
| Disease | Early Pregnancy Loss | 6.31e-06 | 109 | 122 | 6 | C3830362 | |
| Disease | Spontaneous abortion | 6.31e-06 | 109 | 122 | 6 | C0000786 | |
| Disease | Miscarriage | 6.31e-06 | 109 | 122 | 6 | C4552766 | |
| Disease | Abortion, Tubal | 6.31e-06 | 109 | 122 | 6 | C0000822 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 3.63e-05 | 45 | 122 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 5.07e-05 | 3 | 122 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 5.07e-05 | 3 | 122 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 6.12e-05 | 100 | 122 | 5 | C0010606 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.65e-04 | 195 | 122 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | gestational blood glucose measurement | 1.68e-04 | 5 | 122 | 2 | EFO_0009698 | |
| Disease | birth weight | 2.63e-04 | 399 | 122 | 8 | EFO_0004344 | |
| Disease | asymmetrical dimethylarginine measurement, serum dimethylarginine measurement | 3.44e-04 | 33 | 122 | 3 | EFO_0005418, EFO_0006522 | |
| Disease | pulse pressure measurement | PAPPA2 TET2 CNNM2 DDAH1 CCDC30 KDM5A FRYL ZCCHC2 NFATC2 FES ULK4 PRKCE LNX1 FILIP1L TBX2 | 6.38e-04 | 1392 | 122 | 15 | EFO_0005763 |
| Disease | apolipoprotein A 1 measurement | PAPPA2 TET2 THSD7A CRELD2 PJA2 NCOR2 SPON1 FES PCSK7 LRRFIP1 SORL1 | 8.04e-04 | 848 | 122 | 11 | EFO_0004614 |
| Disease | Malignant neoplasm of salivary gland | 8.62e-04 | 45 | 122 | 3 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 9.79e-04 | 47 | 122 | 3 | C0036095 | |
| Disease | breast cancer (is_marker_for) | 1.05e-03 | 185 | 122 | 5 | DOID:1612 (is_marker_for) | |
| Disease | birth weight, parental genotype effect measurement | 1.24e-03 | 192 | 122 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | coronary artery disease | TET2 CNNM2 SORBS2 THSD7A CCDC30 DOCK8 MAP3K1 R3HCC1L LNPEP FES PRKCE LNX1 LRRFIP1 | 1.36e-03 | 1194 | 122 | 13 | EFO_0001645 |
| Disease | Malignant neoplasm of breast | RANBP1 SREBF2 ETV4 COG3 MAP3K1 CNNM4 NOP9 HRG BOD1L1 DNAH9 LRRFIP1 SORL1 | 1.68e-03 | 1074 | 122 | 12 | C0006142 |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 1.72e-03 | 15 | 122 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | body weight | PAPPA2 TET2 CNNM2 NUP88 E2F7 CEP192 DENND1A NFATC2 JRK ULK4 PRKCE LSAMP LNX1 | 2.19e-03 | 1261 | 122 | 13 | EFO_0004338 |
| Disease | Colorectal Carcinoma | 2.61e-03 | 702 | 122 | 9 | C0009402 | |
| Disease | Intellectual Disability | 2.63e-03 | 447 | 122 | 7 | C3714756 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 2.77e-03 | 19 | 122 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | bipolar I disorder | 2.84e-03 | 141 | 122 | 4 | EFO_0009963 | |
| Disease | Craniosynostosis | 3.07e-03 | 20 | 122 | 2 | C0010278 | |
| Disease | serum carcinoembryonic antigen measurement | 3.07e-03 | 20 | 122 | 2 | EFO_0005760 | |
| Disease | alpha-tocopherol measurement | 3.07e-03 | 20 | 122 | 2 | EFO_0007898 | |
| Disease | pulse pressure measurement, alcohol drinking | 3.09e-03 | 70 | 122 | 3 | EFO_0004329, EFO_0005763 | |
| Disease | psychotic symptoms | 3.61e-03 | 74 | 122 | 3 | EFO_0005940 | |
| Disease | response to clopidogrel, cardiovascular event measurement | 4.05e-03 | 23 | 122 | 2 | EFO_0006919, GO_1903493 | |
| Disease | unipolar depression, bipolar disorder | 4.07e-03 | 156 | 122 | 4 | EFO_0003761, MONDO_0004985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVAVCPPKEYDDELT | 536 | Q9Y6N9 | |
| KKCEAEEAEPPAATQ | 731 | Q9UKV3 | |
| CLEPEPELRSTFSEE | 261 | Q7L4P6 | |
| AFECDEDKDEREAPP | 461 | Q96RT1 | |
| VLESPKKTICDPEEF | 16 | Q15052 | |
| PIDSESKEDEPCSEE | 1346 | P13611 | |
| PVEDKDAVAFTCEPE | 156 | P06731 | |
| KPVEDKDAVAFTCEP | 511 | P06731 | |
| PVEDKDAVAFTCEPE | 156 | P31997 | |
| KNDTLDPEPFVDCKE | 1271 | Q92793 | |
| FVEAEVPDVDLECPD | 1821 | Q09666 | |
| IPKCLEFEKAEPTDV | 1336 | Q96MT7 | |
| FPDDVCVVPEKFEGD | 306 | P43268 | |
| SDRPCEISEIDDNPK | 66 | Q96PE5 | |
| EVPDIDLSDCEFPHV | 631 | Q7Z5L2 | |
| ADFADECPKPELLAI | 126 | P43487 | |
| AKSQPDPFCETDSDE | 1296 | O95153 | |
| PVCEKTLYSDTIPED | 3021 | Q14517 | |
| PVKSECTEEAEEGPA | 861 | Q9Y618 | |
| IKTEPTDEYDPTLIC | 681 | Q13469 | |
| IKEEPLSEEEPCTST | 496 | Q9Y2X3 | |
| ECKPADFEVPETFLN | 241 | Q86U38 | |
| EPVDVKPFASCEDSE | 536 | Q96RG2 | |
| PTDCSAVEPEAEKAL | 21 | P04196 | |
| DEEICAKEANPPTAA | 196 | Q9Y561 | |
| ILEEEEESPPSASAC | 31 | Q96LZ2 | |
| CEELDSEKPADPLSA | 61 | A8MVJ9 | |
| FPKVFVEDCATTDLE | 506 | P19878 | |
| PDAVAVDCKDPDDVV | 31 | Q9Y287 | |
| DIDPEIETECFFVEP | 176 | Q8TDD5 | |
| DPKEISPVIDQFIEC | 391 | Q9Y216 | |
| SAPTSPCDQEIKELE | 346 | Q02156 | |
| PVEDKDAVAFTCEPE | 156 | P40199 | |
| ESVPLCSSKDPDEVE | 721 | Q16549 | |
| SSEEELEAECFPVKP | 396 | O75564 | |
| PEKEKESPAELAERC | 221 | Q9Y2G0 | |
| PESYPESVCEEDVTL | 2611 | O94915 | |
| TTSVLDCEEDETPKP | 316 | Q5H8C1 | |
| DCEEDETPKPLLVFN | 321 | Q5H8C1 | |
| PDSPETSKEVNALEC | 391 | Q9Y2U5 | |
| CEDVAALDPVTFESP | 486 | Q9P2S2 | |
| EVKEYEPQEDCSSPA | 591 | Q8TBB1 | |
| FEEEPDVVDLAKEPC | 21 | Q9UIQ6 | |
| SCPRPDEVEDSSEFV | 156 | Q8N8V2 | |
| TCTPEEEENEEKPLL | 256 | Q6NV74 | |
| PNLFCDEEIPIKSEE | 1371 | P29375 | |
| EPCDSPKVKEERIDT | 1516 | O94913 | |
| DPQVADVRKTCFDPD | 646 | Q9BXP8 | |
| LETAPKSEEFSDLPC | 271 | Q8NFC6 | |
| KSEEFSDLPCPVEEI | 276 | Q8NFC6 | |
| EASEIKLEPSFEDSC | 261 | O43313 | |
| TEASRPLPEDFCLKE | 201 | Q8WV48 | |
| PLPEDFCLKEDEEEI | 206 | Q8WV48 | |
| TLELSCDKFPPEEEL | 306 | P15169 | |
| LCEERKPQEEDEPAT | 596 | Q96AV8 | |
| FTDDDLDVVFTPKEC | 86 | Q8NF50 | |
| CPPDDTKLIEDEFII | 291 | Q03188 | |
| PVEDKDAVAFTCEPE | 156 | P13688 | |
| QDKDSPSESDVILPC | 36 | Q4L180 | |
| KEEFSPEDIQIIACP | 801 | Q96JB2 | |
| TPFEELIKCEEDLPT | 46 | Q9H1P6 | |
| CFEITVELSCEKFPP | 336 | P16870 | |
| TCKDPESNEPILETE | 116 | Q5VVM6 | |
| IVSFTPKDPEACEER | 1711 | Q8TEP8 | |
| ESFEAKDELCPEKPS | 381 | Q8NEP3 | |
| ALKIEPEEPITFCEE | 326 | Q8TEH3 | |
| EPACPFSQKDKEVAE | 736 | Q9UEF7 | |
| DLPFPEQACCAEEEK | 451 | Q16610 | |
| LTTEDIPADCPKEIY | 2356 | Q9NYC9 | |
| ECPPEELARDSEKKS | 811 | Q14527 | |
| CFAEEKTEIPKDLPA | 1316 | Q8NDH2 | |
| TEDACVPPAEAEATE | 326 | Q6UXH1 | |
| QFKDGTDEEDCPLPE | 2011 | P21817 | |
| PADESLPDCVFVEDV | 66 | O94760 | |
| AEPKSEDADRCTLPE | 716 | Q32MZ4 | |
| SSSDEEEDPPAKRKC | 476 | O75928 | |
| EDDPFDSDFSCPVKL | 381 | Q99567 | |
| PCVTFDESLLEEGEP | 276 | P07332 | |
| IPSDETVFTPVEEKC | 1106 | Q13233 | |
| KPLPVEDSDCSSDET | 71 | Q8TC99 | |
| AEGETKPDPDVTERC | 36 | P02790 | |
| EGEFPTEEVTCKEPI | 311 | Q8IZ73 | |
| PEEKDEDDTPETCIY | 431 | Q9HCB6 | |
| SEDLSLEVCVPDPEF | 691 | Q92673 | |
| KECPEFEEKEPCLSQ | 401 | Q9UPZ6 | |
| PPEQSDLKLVCSDFE | 1231 | A2VDJ0 | |
| SLKCEASAVPAPDFE | 236 | Q13449 | |
| EESACVKDEKFAPPL | 226 | Q5H9M0 | |
| PACSVEIVVPKEEDA | 581 | O60331 | |
| SLQDPEEPSFCLEAE | 476 | Q8TE82 | |
| ETEPEEDLKPEACFT | 1156 | Q9NY46 | |
| LEFPSLPQCKEDAEE | 6 | Q8WUJ0 | |
| DLLNDDCDSFPDPKV | 386 | O94875 | |
| FFPSPESSCDVKLVE | 86 | P01848 | |
| DSCSDEEPAEILEFP | 5601 | Q8IVF2 | |
| LCEPDPVHFSEAIEK | 361 | Q9H553 | |
| VKDLAFVDPDDCTPL | 481 | Q9NRU3 | |
| FVKDLAFVDPDDCTP | 496 | Q9H8M5 | |
| KDLAFVDPEDCTPLS | 366 | Q8NE01 | |
| DLAFVDPDDCTPLKT | 426 | Q6P4Q7 | |
| EDAEVEVEPCKFAGP | 296 | Q9C0B9 | |
| KQPCPSESDIITEED | 201 | O75475 | |
| CEPAESQPEALSEKE | 431 | P82094 | |
| AEEKSCAADSDPEPE | 351 | Q13207 | |
| VTSEALKDPDVCTDP | 51 | Q6P161 | |
| FFPSPESSCDVKLVE | 221 | P0DTU3 | |
| EKEQPTEEEERCPTT | 1941 | Q15413 | |
| DSSCKTPEVSFLPEE | 996 | Q9H7N4 | |
| DFPVCVSTKPEPEDD | 141 | Q6VEQ5 | |
| SQEKCFVVPEEPDAA | 681 | Q9H9D4 | |
| AECAEEKIPPSTLVE | 701 | Q12772 | |
| TLEPKPDTDKFLETC | 456 | Q6IQ55 | |
| DFPVCVSTKPEPEDD | 141 | A8K0Z3 | |
| CFEESAKEAPPSLEQ | 571 | P16471 | |
| DPVRTCFETFPDKVA | 321 | P11216 | |
| FPSDETCEKPVDETT | 141 | Q5JSH3 | |
| APCFPVESKEEEQIE | 756 | P11137 | |
| IAAKEKEESEPTCEP | 211 | O43167 | |
| KEESEPTCEPSREEE | 216 | O43167 | |
| CKESEERVPDSEQTP | 101 | Q8WUU8 | |
| PDIPFCEFAETVSKD | 1336 | Q8N9V7 | |
| LDPASFTEITKDCDE | 766 | Q86T82 | |
| EAECPEDARLSPEKS | 1441 | Q96JM2 | |
| SPESCPEEIKHEEFD | 521 | Q92889 | |
| EDDCVVHLAPPSEEF | 151 | Q96KN8 | |
| PKPAAVVSEACDADD | 286 | Q6N021 | |
| SEPIFEKSETEIPTC | 91 | O43164 | |
| VCVSTKPEPEDDAEE | 126 | Q9NQA3 | |
| EKCDEIPDSEPILEF | 866 | Q9BVV6 | |
| FCLEEEPSVETEDPS | 31 | O60304 | |
| PNEDPEIFDVSSKCL | 1166 | Q96C45 | |
| VAPEKDESPVSICED | 111 | Q8NC26 | |
| LCPSYELPDTKFEEE | 136 | O14777 |